DENTSPLY SIRONA Inc (XRAY)
NASDAQ:XRAY
Want to see XRAY full AI Analyst Report?
XRAY Stock Chart & Stats
$12.51
-$0.04(-0.21%)
At close: 4:00 PM EST
$12.51
-$0.04(-0.21%)
Day’s Range― - ―
52-Week Range$9.85 - $17.18
Previous CloseN/A
Volume461.38K
Average Volume (3M)3.65M
Market Cap
$2.37B
Enterprise Value$4.39B
Total Cash (Recent Filing)$326.00M
Total Debt (Recent Filing)$2.47B
Price to Earnings (P/E)―
Beta0.71
Next Earnings
May 05, 2026EPS Estimate
0.28Next Dividend Ex-DateN/A
Dividend Yield5.61%
Share Statistics
EPS (TTM)-3.00
Shares Outstanding200,320,500
10 Day Avg. Volume2,898,095
30 Day Avg. Volume3,645,346
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.70
Price to Sales (P/S)0.62
P/FCF Ratio21.91
Enterprise Value/Market Cap1.85
Enterprise Value/Revenue1.19
Enterprise Value/Gross Profit2.38
Enterprise Value/Ebitda-97.46
Forecast
1Y Price Target
$14.27Price Target Upside14.09% Upside
Rating ConsensusHold
Number of Analyst Covering13
EPS Forecast (FY)1.42
Revenue Forecast (FY)$3.58B
Bulls Say, Bears Say
Bulls Say
Capital Allocation And BuybacksManagement eliminated the dividend and plans to redeploy cash toward debt reduction and share repurchases, increasing financial flexibility to support operational stabilization and potential shareholder value recovery.
Earnings CadenceAnalyst adjusted the financial model to align with management comments on the expected pattern of earnings per share, creating clearer expectations for the company's earnings cadence.
Revenue And Segment PerformanceRevenue and all major business segments exceeded analyst expectations, indicating broad operational improvement and stronger demand across core markets.
Bears Say
Interest Expense PressureAnalyst revised interest expense assumptions upward, which raises projected financing costs and can reduce net earnings.
Leverage And Financial RiskElevated leverage increases financial risk and may limit the company's ability to invest in growth initiatives or respond to adverse events.
Mixed Results And Uncertain MomentumReported results and guidance were mixed, creating uncertainty about near-term financial momentum and prompting analysts to seek more tangible progress before upgrading recommendations.
DENTSPLY SIRONA News
XRAY FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
DENTSPLY SIRONA Inc lowest stock price was $9.85 and its highest was $17.18 in the past 12 months.
What is DENTSPLY SIRONA Inc’s market cap?
DENTSPLY SIRONA Inc’s market cap is $2.37B.
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is May 05, 2026 which is today.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
Currently, no data Available
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Undervalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 5.61%. See more information on DENTSPLY SIRONA Inc dividends here
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is 0.28.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 200,320,500 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Currently, no hedge funds are holding shares in XRAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.27 (14.09% Upside)
$14.27 (14.09% Upside)
Blogger Sentiment
Bullish
XRAY Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 6.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 1.6%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.22%
12-Months-Change
Fundamentals
Return on Equity
-35.24%
Trailing 12-Months
Asset Growth
-5.63%
Trailing 12-Months
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
XRAY Company Deck
XRAY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a mixed but constructive tone: management reported a solid Q4 finish and full-year margin improvement while acknowledging material topline pressures (FY revenue decline, implant and CAD/CAM weakness), a sizable goodwill impairment and tariff headwinds. Leadership laid out a detailed 24-month Return to Growth plan with increased R&D and commercial investments, a $120M run-rate cost savings target, strategic hires, dealership agreements and a capital allocation shift (dividend elimination) to prioritize debt reduction and buybacks. Near-term execution risks (restructuring charges, inventory model transition, Byte comparability) and persistent volume weakness temper optimism but the strategy and financial actions provide a clear roadmap to restore growth and improve cash generation over time.View all XRAY earnings summariesXRAY Net sales Breakdown
15.71% Equipment & Instruments
12.45% CAD/CAM
39.92% Essential Dental Solutions
6.17% Orthodontics
16.93% Implants & Prosthetics
8.83% Wellspect Healthcare
XRAY Stock 12 Month Forecast
Average Price Target
$14.27
▲(14.09% Upside)
Technical Analysis
Ownership Overview
0.66% Insiders
33.64% Mutual Funds
1.98% Other Institutional Investors
44.67% Public Companies and
Individual Investors